Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone Tablets vs Capsules for Endometrial Thickness in Post-Menopausal Women
NCT02841137Phase 2Completed
- Sponsor
- IBSA Group
- Start
- Jun 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of progesterone in menopause (4 arms), sponsored by IBSA Group. Primary endpoint: Endometrial thickness change towards baseline at 3 months. Started Jun 2016; status: completed.
02
Drugs
progesterone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT02841137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841137.